Thanks for your confirmation. So IMU is dosing patients who are not going through chemo. That means, their immune system is not compromised yet. In that case, we may well yet be surprised after the first or second cohort where they also observe efficacy other than safety and tolerability.
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-52
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(3.64%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.3¢ | $387.6K | 7.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 1468230 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 647059 | 15 |
View Market Depth
| Last trade - 12.36pm 12/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |